BCAX Stock-Based Compensation
Bicara Therapeutics Inc · Stock-Based Compensation
BCAX Stock-Based Compensation
Latest reported$22.16Mperiod ending
BCAX Stock-Based Comp ($810.00K → $22.16M)
Annual stock-based compensation
High-resolution chart · PNG
BCAX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 15,006,000 | |
| 7,397,000 | |
| 1,899,000 | |
| 810,000 |